Before you sell to, join or invest in ORF Biologics, Inc.
MentionFox check on ORF Biologics, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/orf-biologics-inc-form-d-24000001
Check ORF Biologics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
ORF Biologics, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-12.
ORF Biologics, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 12, 2024. Its industry group is Biotechnology. It names Steven Michalicek (Director), Anant Kamath (Executive Officer, Director), Jay Kamath (Executive Officer, Director) (SEC Form D, December 12, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like ORF Biologics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ORF Biologics, Inc.
Free to see. No signup.
Get an email when ORF Biologics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ORF Biologics, Inc. raises, hires or launches. No email unless you switch it on.
Watch ORF Biologics, Inc. →Get the full cited report on ORF Biologics, Inc.
What the filing shows about ORF Biologics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ORF Biologics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ORF Biologics, Inc.'s address as 2875 Ash St., Coralville, IA 52241.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for ORF Biologics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
ORF Biologics, Inc. is a registered filer with the SEC (CIK 2048350) and has filed since 2024-12-12. 2 filings are on record, the latest on 2026-07-31.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ORF Biologics, Inc.'s Form D of 2024-12-12 names Steven Michalicek, Anant Kamath, Jay Kamath and 2 more as its officers, directors or promoters.
Its new offerings report $1.73M sold across 1 offering, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Steven Michalicek is named as Director on the Form D that ORF Biologics, Inc. filed with the SEC on 12 December 2024, one of 5 people that filing names.
Anant Kamath is named as Executive Officer and Director on the Form D that ORF Biologics, Inc. filed with the SEC on 12 December 2024, one of 5 people that filing names.
Jay Kamath is named as Executive Officer and Director on the Form D that ORF Biologics, Inc. filed with the SEC on 12 December 2024, one of 5 people that filing names.
Sara Ternes is named as Executive Officer and Director on the Form D that ORF Biologics, Inc. filed with the SEC on 12 December 2024, one of 5 people that filing names.
Stephen Hanson is named as Executive Officer and Director on the Form D that ORF Biologics, Inc. filed with the SEC on 12 December 2024, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2024-12-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ORF Biologics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ORF Biologics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ORF Biologics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ORF Biologics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind ORF Biologics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for ORF Biologics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/orf-biologics-inc-form-d-24000001